img

Global Antidiabetic Biguanides Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antidiabetic Biguanides Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Antidiabetic Biguanides report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antidiabetic Biguanides market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Antidiabetic Biguanides industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Antidiabetic Biguanides key manufacturers include Pfizer, AstraZeneca, GlaxoSmithKline, Merck & Co, Eli Lilly, Sanofi, Takeda Pharmaceuticals, Novo Nordisk and Servier Laboratories, etc. Pfizer, AstraZeneca, GlaxoSmithKline are top 3 players and held % sales share in total in 2022.
Antidiabetic Biguanides can be divided into Metformin IR and Metformin SR, etc. Metformin IR is the mainstream product in the market, accounting for % sales share globally in 2022.
Antidiabetic Biguanides is widely used in various fields, such as Hospitals, Clinics and Other,, etc. Hospitals provides greatest supports to the Antidiabetic Biguanides industry development. In 2022, global % sales of Antidiabetic Biguanides went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antidiabetic Biguanides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
AstraZeneca
GlaxoSmithKline
Merck & Co
Eli Lilly
Sanofi
Takeda Pharmaceuticals
Novo Nordisk
Servier Laboratories
Boehringer Ingelheim
Bristol-Myers Squibb
Segment by Type
Metformin IR
Metformin SR

Segment by Application


Hospitals
Clinics
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Antidiabetic Biguanides market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antidiabetic Biguanides, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antidiabetic Biguanides industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Antidiabetic Biguanides in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antidiabetic Biguanides introduction, etc. Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Antidiabetic Biguanides market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Antidiabetic Biguanides Market Overview
1.1 Antidiabetic Biguanides Product Overview
1.2 Antidiabetic Biguanides Market Segment by Type
1.2.1 Metformin IR
1.2.2 Metformin SR
1.3 Global Antidiabetic Biguanides Market Size by Type
1.3.1 Global Antidiabetic Biguanides Market Size Overview by Type (2018-2034)
1.3.2 Global Antidiabetic Biguanides Historic Market Size Review by Type (2018-2024)
1.3.3 Global Antidiabetic Biguanides Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antidiabetic Biguanides Sales Breakdown by Type (2018-2024)
1.4.2 Europe Antidiabetic Biguanides Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Antidiabetic Biguanides Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Antidiabetic Biguanides Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Antidiabetic Biguanides Sales Breakdown by Type (2018-2024)
2 Global Antidiabetic Biguanides Market Competition by Company
2.1 Global Top Players by Antidiabetic Biguanides Sales (2018-2024)
2.2 Global Top Players by Antidiabetic Biguanides Revenue (2018-2024)
2.3 Global Top Players by Antidiabetic Biguanides Price (2018-2024)
2.4 Global Top Manufacturers Antidiabetic Biguanides Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antidiabetic Biguanides Market Competitive Situation and Trends
2.5.1 Antidiabetic Biguanides Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Antidiabetic Biguanides Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antidiabetic Biguanides as of 2022)
2.7 Date of Key Manufacturers Enter into Antidiabetic Biguanides Market
2.8 Key Manufacturers Antidiabetic Biguanides Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antidiabetic Biguanides Status and Outlook by Region
3.1 Global Antidiabetic Biguanides Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Antidiabetic Biguanides Historic Market Size by Region
3.2.1 Global Antidiabetic Biguanides Sales in Volume by Region (2018-2024)
3.2.2 Global Antidiabetic Biguanides Sales in Value by Region (2018-2024)
3.2.3 Global Antidiabetic Biguanides Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Antidiabetic Biguanides Forecasted Market Size by Region
3.3.1 Global Antidiabetic Biguanides Sales in Volume by Region (2024-2034)
3.3.2 Global Antidiabetic Biguanides Sales in Value by Region (2024-2034)
3.3.3 Global Antidiabetic Biguanides Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Antidiabetic Biguanides by Application
4.1 Antidiabetic Biguanides Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Other
4.2 Global Antidiabetic Biguanides Market Size by Application
4.2.1 Global Antidiabetic Biguanides Market Size Overview by Application (2018-2034)
4.2.2 Global Antidiabetic Biguanides Historic Market Size Review by Application (2018-2024)
4.2.3 Global Antidiabetic Biguanides Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antidiabetic Biguanides Sales Breakdown by Application (2018-2024)
4.3.2 Europe Antidiabetic Biguanides Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Antidiabetic Biguanides Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Antidiabetic Biguanides Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Antidiabetic Biguanides Sales Breakdown by Application (2018-2024)
5 North America Antidiabetic Biguanides by Country
5.1 North America Antidiabetic Biguanides Historic Market Size by Country
5.1.1 North America Antidiabetic Biguanides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Antidiabetic Biguanides Sales in Volume by Country (2018-2024)
5.1.3 North America Antidiabetic Biguanides Sales in Value by Country (2018-2024)
5.2 North America Antidiabetic Biguanides Forecasted Market Size by Country
5.2.1 North America Antidiabetic Biguanides Sales in Volume by Country (2024-2034)
5.2.2 North America Antidiabetic Biguanides Sales in Value by Country (2024-2034)
6 Europe Antidiabetic Biguanides by Country
6.1 Europe Antidiabetic Biguanides Historic Market Size by Country
6.1.1 Europe Antidiabetic Biguanides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Antidiabetic Biguanides Sales in Volume by Country (2018-2024)
6.1.3 Europe Antidiabetic Biguanides Sales in Value by Country (2018-2024)
6.2 Europe Antidiabetic Biguanides Forecasted Market Size by Country
6.2.1 Europe Antidiabetic Biguanides Sales in Volume by Country (2024-2034)
6.2.2 Europe Antidiabetic Biguanides Sales in Value by Country (2024-2034)
7 Asia-Pacific Antidiabetic Biguanides by Region
7.1 Asia-Pacific Antidiabetic Biguanides Historic Market Size by Region
7.1.1 Asia-Pacific Antidiabetic Biguanides Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Antidiabetic Biguanides Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Antidiabetic Biguanides Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Antidiabetic Biguanides Forecasted Market Size by Region
7.2.1 Asia-Pacific Antidiabetic Biguanides Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Antidiabetic Biguanides Sales in Value by Region (2024-2034)
8 Latin America Antidiabetic Biguanides by Country
8.1 Latin America Antidiabetic Biguanides Historic Market Size by Country
8.1.1 Latin America Antidiabetic Biguanides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Antidiabetic Biguanides Sales in Volume by Country (2018-2024)
8.1.3 Latin America Antidiabetic Biguanides Sales in Value by Country (2018-2024)
8.2 Latin America Antidiabetic Biguanides Forecasted Market Size by Country
8.2.1 Latin America Antidiabetic Biguanides Sales in Volume by Country (2024-2034)
8.2.2 Latin America Antidiabetic Biguanides Sales in Value by Country (2024-2034)
9 Middle East and Africa Antidiabetic Biguanides by Country
9.1 Middle East and Africa Antidiabetic Biguanides Historic Market Size by Country
9.1.1 Middle East and Africa Antidiabetic Biguanides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Antidiabetic Biguanides Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Antidiabetic Biguanides Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Antidiabetic Biguanides Forecasted Market Size by Country
9.2.1 Middle East and Africa Antidiabetic Biguanides Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Antidiabetic Biguanides Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Antidiabetic Biguanides Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Antidiabetic Biguanides Products Offered
10.1.5 Pfizer Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca Antidiabetic Biguanides Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AstraZeneca Antidiabetic Biguanides Products Offered
10.2.5 AstraZeneca Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Information
10.3.2 GlaxoSmithKline Introduction and Business Overview
10.3.3 GlaxoSmithKline Antidiabetic Biguanides Sales, Revenue and Gross Margin (2018-2024)
10.3.4 GlaxoSmithKline Antidiabetic Biguanides Products Offered
10.3.5 GlaxoSmithKline Recent Development
10.4 Merck & Co
10.4.1 Merck & Co Company Information
10.4.2 Merck & Co Introduction and Business Overview
10.4.3 Merck & Co Antidiabetic Biguanides Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Merck & Co Antidiabetic Biguanides Products Offered
10.4.5 Merck & Co Recent Development
10.5 Eli Lilly
10.5.1 Eli Lilly Company Information
10.5.2 Eli Lilly Introduction and Business Overview
10.5.3 Eli Lilly Antidiabetic Biguanides Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Eli Lilly Antidiabetic Biguanides Products Offered
10.5.5 Eli Lilly Recent Development
10.6 Sanofi
10.6.1 Sanofi Company Information
10.6.2 Sanofi Introduction and Business Overview
10.6.3 Sanofi Antidiabetic Biguanides Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Sanofi Antidiabetic Biguanides Products Offered
10.6.5 Sanofi Recent Development
10.7 Takeda Pharmaceuticals
10.7.1 Takeda Pharmaceuticals Company Information
10.7.2 Takeda Pharmaceuticals Introduction and Business Overview
10.7.3 Takeda Pharmaceuticals Antidiabetic Biguanides Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Takeda Pharmaceuticals Antidiabetic Biguanides Products Offered
10.7.5 Takeda Pharmaceuticals Recent Development
10.8 Novo Nordisk
10.8.1 Novo Nordisk Company Information
10.8.2 Novo Nordisk Introduction and Business Overview
10.8.3 Novo Nordisk Antidiabetic Biguanides Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Novo Nordisk Antidiabetic Biguanides Products Offered
10.8.5 Novo Nordisk Recent Development
10.9 Servier Laboratories
10.9.1 Servier Laboratories Company Information
10.9.2 Servier Laboratories Introduction and Business Overview
10.9.3 Servier Laboratories Antidiabetic Biguanides Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Servier Laboratories Antidiabetic Biguanides Products Offered
10.9.5 Servier Laboratories Recent Development
10.10 Boehringer Ingelheim
10.10.1 Boehringer Ingelheim Company Information
10.10.2 Boehringer Ingelheim Introduction and Business Overview
10.10.3 Boehringer Ingelheim Antidiabetic Biguanides Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Boehringer Ingelheim Antidiabetic Biguanides Products Offered
10.10.5 Boehringer Ingelheim Recent Development
10.11 Bristol-Myers Squibb
10.11.1 Bristol-Myers Squibb Company Information
10.11.2 Bristol-Myers Squibb Introduction and Business Overview
10.11.3 Bristol-Myers Squibb Antidiabetic Biguanides Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Bristol-Myers Squibb Antidiabetic Biguanides Products Offered
10.11.5 Bristol-Myers Squibb Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antidiabetic Biguanides Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antidiabetic Biguanides Industrial Chain Analysis
11.4 Antidiabetic Biguanides Market Dynamics
11.4.1 Antidiabetic Biguanides Industry Trends
11.4.2 Antidiabetic Biguanides Market Drivers
11.4.3 Antidiabetic Biguanides Market Challenges
11.4.4 Antidiabetic Biguanides Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antidiabetic Biguanides Distributors
12.3 Antidiabetic Biguanides Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Metformin IR
Table 2. Major Company of Metformin SR
Table 3. Global Antidiabetic Biguanides Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Antidiabetic Biguanides Sales by Type (2018-2024) & (K Pcs)
Table 5. Global Antidiabetic Biguanides Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Antidiabetic Biguanides Sales by Type (2018-2024) & (US& Million)
Table 7. Global Antidiabetic Biguanides Market Share in Value by Type (2018-2024)
Table 8. Global Antidiabetic Biguanides Price by Type (2018-2024) & (USD/Pcs)
Table 9. Global Antidiabetic Biguanides Sales by Type (2024-2034) & (K Pcs)
Table 10. Global Antidiabetic Biguanides Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Antidiabetic Biguanides Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Antidiabetic Biguanides Sales Market Share in Value by Type (2024-2034)
Table 13. Global Antidiabetic Biguanides Price by Type (2024-2034) & (USD/Pcs)
Table 14. North America Antidiabetic Biguanides Sales by Type (2018-2024) & (K Pcs)
Table 15. North America Antidiabetic Biguanides Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Antidiabetic Biguanides Sales (K Pcs) by Type (2018-2024)
Table 17. Europe Antidiabetic Biguanides Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Antidiabetic Biguanides Sales (K Pcs) by Type (2018-2024)
Table 19. Asia-Pacific Antidiabetic Biguanides Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Antidiabetic Biguanides Sales (K Pcs) by Type (2018-2024)
Table 21. Latin America Antidiabetic Biguanides Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Antidiabetic Biguanides Sales (K Pcs) by Type (2018-2024)
Table 23. Middle East and Africa Antidiabetic Biguanides Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Antidiabetic Biguanides Sales by Company (2018-2024) & (K Pcs)
Table 25. Global Antidiabetic Biguanides Sales Share by Company (2018-2024)
Table 26. Global Antidiabetic Biguanides Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Antidiabetic Biguanides Revenue Share by Company (2018-2024)
Table 28. Global Market Antidiabetic Biguanides Price by Company (2018-2024) & (USD/Pcs)
Table 29. Global Antidiabetic Biguanides Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Antidiabetic Biguanides Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antidiabetic Biguanides as of 2022)
Table 32. Date of Key Manufacturers Enter into Antidiabetic Biguanides Market
Table 33. Key Manufacturers Antidiabetic Biguanides Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Antidiabetic Biguanides Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Antidiabetic Biguanides Sales by Region (2018-2024) & (K Pcs)
Table 37. Global Antidiabetic Biguanides Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Antidiabetic Biguanides Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Antidiabetic Biguanides Sales Market Share in Value by Region (2018-2024)
Table 40. Global Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 41. Global Antidiabetic Biguanides Sales by Region (2024-2034) & (K Pcs)
Table 42. Global Antidiabetic Biguanides Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Antidiabetic Biguanides Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Antidiabetic Biguanides Sales Market Share in Value by Region (2024-2034)
Table 45. Global Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 46. Global Antidiabetic Biguanides Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Antidiabetic Biguanides Sales by Application (2018-2024) & (K Pcs)
Table 48. Global Antidiabetic Biguanides Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Antidiabetic Biguanides Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Antidiabetic Biguanides Sales Market Share in Value by Application (2018-2024)
Table 51. Global Antidiabetic Biguanides Price by Application (2018-2024) & (USD/Pcs)
Table 52. Global Antidiabetic Biguanides Sales by Application (2024-2034) & (K Pcs)
Table 53. Global Antidiabetic Biguanides Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Antidiabetic Biguanides Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Antidiabetic Biguanides Sales Market Share in Value by Application (2024-2034)
Table 56. Global Antidiabetic Biguanides Price by Application (2024-2034) & (USD/Pcs)
Table 57. North America Antidiabetic Biguanides Sales by Application (2018-2024) (K Pcs)
Table 58. North America Antidiabetic Biguanides Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Antidiabetic Biguanides Sales by Application (2018-2024) (K Pcs)
Table 60. Europe Antidiabetic Biguanides Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Antidiabetic Biguanides Sales by Application (2018-2024) (K Pcs)
Table 62. Asia-Pacific Antidiabetic Biguanides Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Antidiabetic Biguanides Sales by Application (2018-2024) (K Pcs)
Table 64. Latin America Antidiabetic Biguanides Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Antidiabetic Biguanides Sales by Application (2018-2024) (K Pcs)
Table 66. Middle East and Africa Antidiabetic Biguanides Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Antidiabetic Biguanides Sales by Country (2018-2024) & (K Pcs)
Table 68. North America Antidiabetic Biguanides Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Antidiabetic Biguanides Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Antidiabetic Biguanides Sales Market Share in Value by Country (2018-2024)
Table 71. North America Antidiabetic Biguanides Sales by Country (2024-2034) & (K Pcs)
Table 72. North America Antidiabetic Biguanides Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Antidiabetic Biguanides Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Antidiabetic Biguanides Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Antidiabetic Biguanides Sales by Country (2018-2024) & (K Pcs)
Table 76. Europe Antidiabetic Biguanides Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Antidiabetic Biguanides Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Antidiabetic Biguanides Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Antidiabetic Biguanides Sales by Country (2024-2034) & (K Pcs)
Table 80. Europe Antidiabetic Biguanides Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Antidiabetic Biguanides Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Antidiabetic Biguanides Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Antidiabetic Biguanides Sales by Region (2018-2024) & (K Pcs)
Table 84. Asia-Pacific Antidiabetic Biguanides Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Antidiabetic Biguanides Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Antidiabetic Biguanides Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Antidiabetic Biguanides Sales by Region (2024-2034) & (K Pcs)
Table 88. Asia-Pacific Antidiabetic Biguanides Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Antidiabetic Biguanides Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Antidiabetic Biguanides Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Antidiabetic Biguanides Sales by Country (2018-2024) & (K Pcs)
Table 92. Latin America Antidiabetic Biguanides Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Antidiabetic Biguanides Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Antidiabetic Biguanides Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Antidiabetic Biguanides Sales by Country (2024-2034) & (K Pcs)
Table 96. Latin America Antidiabetic Biguanides Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Antidiabetic Biguanides Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Antidiabetic Biguanides Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Antidiabetic Biguanides Sales by Country (2018-2024) & (K Pcs)
Table 100. Middle East and Africa Antidiabetic Biguanides Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Antidiabetic Biguanides Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Antidiabetic Biguanides Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Antidiabetic Biguanides Sales by Country (2024-2034) & (K Pcs)
Table 104. Middle East and Africa Antidiabetic Biguanides Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Antidiabetic Biguanides Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Antidiabetic Biguanides Sales Market Share in Value by Country (2024-2034)
Table 107. Pfizer Company Information
Table 108. Pfizer Introduction and Business Overview
Table 109. Pfizer Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 110. Pfizer Antidiabetic Biguanides Product
Table 111. Pfizer Recent Development
Table 112. AstraZeneca Company Information
Table 113. AstraZeneca Introduction and Business Overview
Table 114. AstraZeneca Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 115. AstraZeneca Antidiabetic Biguanides Product
Table 116. AstraZeneca Recent Development
Table 117. GlaxoSmithKline Company Information
Table 118. GlaxoSmithKline Introduction and Business Overview
Table 119. GlaxoSmithKline Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 120. GlaxoSmithKline Antidiabetic Biguanides Product
Table 121. GlaxoSmithKline Recent Development
Table 122. Merck & Co Company Information
Table 123. Merck & Co Introduction and Business Overview
Table 124. Merck & Co Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 125. Merck & Co Antidiabetic Biguanides Product
Table 126. Merck & Co Recent Development
Table 127. Eli Lilly Company Information
Table 128. Eli Lilly Introduction and Business Overview
Table 129. Eli Lilly Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 130. Eli Lilly Antidiabetic Biguanides Product
Table 131. Eli Lilly Recent Development
Table 132. Sanofi Company Information
Table 133. Sanofi Introduction and Business Overview
Table 134. Sanofi Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 135. Sanofi Antidiabetic Biguanides Product
Table 136. Sanofi Recent Development
Table 137. Takeda Pharmaceuticals Company Information
Table 138. Takeda Pharmaceuticals Introduction and Business Overview
Table 139. Takeda Pharmaceuticals Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 140. Takeda Pharmaceuticals Antidiabetic Biguanides Product
Table 141. Takeda Pharmaceuticals Recent Development
Table 142. Novo Nordisk Company Information
Table 143. Novo Nordisk Introduction and Business Overview
Table 144. Novo Nordisk Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 145. Novo Nordisk Antidiabetic Biguanides Product
Table 146. Novo Nordisk Recent Development
Table 147. Servier Laboratories Company Information
Table 148. Servier Laboratories Introduction and Business Overview
Table 149. Servier Laboratories Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 150. Servier Laboratories Antidiabetic Biguanides Product
Table 151. Servier Laboratories Recent Development
Table 152. Boehringer Ingelheim Company Information
Table 153. Boehringer Ingelheim Introduction and Business Overview
Table 154. Boehringer Ingelheim Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 155. Boehringer Ingelheim Antidiabetic Biguanides Product
Table 156. Boehringer Ingelheim Recent Development
Table 157. Bristol-Myers Squibb Company Information
Table 158. Bristol-Myers Squibb Introduction and Business Overview
Table 159. Bristol-Myers Squibb Antidiabetic Biguanides Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 160. Bristol-Myers Squibb Antidiabetic Biguanides Product
Table 161. Bristol-Myers Squibb Recent Development
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Antidiabetic Biguanides Market Trends
Table 165. Antidiabetic Biguanides Market Drivers
Table 166. Antidiabetic Biguanides Market Challenges
Table 167. Antidiabetic Biguanides Market Restraints
Table 168. Antidiabetic Biguanides Distributors List
Table 169. Antidiabetic Biguanides Downstream Customers
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Antidiabetic Biguanides Product Picture
Figure 2. Global Antidiabetic Biguanides Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Antidiabetic Biguanides Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Antidiabetic Biguanides Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Metformin IR
Figure 6. Global Metformin IR Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Metformin SR
Figure 8. Global Metformin SR Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Global Antidiabetic Biguanides Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Antidiabetic Biguanides Sales Market Share by Type in 2022 & 2034
Figure 11. North America Antidiabetic Biguanides Sales Market Share in Volume by Type in 2022
Figure 12. North America Antidiabetic Biguanides Sales Market Share in Value by Type in 2022
Figure 13. Europe Antidiabetic Biguanides Sales Market Share in Volume by Type in 2022
Figure 14. Europe Antidiabetic Biguanides Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Antidiabetic Biguanides Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Antidiabetic Biguanides Sales Market Share in Value by Type in 2022
Figure 17. Latin America Antidiabetic Biguanides Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Antidiabetic Biguanides Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Antidiabetic Biguanides Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Antidiabetic Biguanides Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Antidiabetic Biguanides Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Antidiabetic Biguanides Revenue in 2022
Figure 23. Antidiabetic Biguanides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospitals
Figure 25. Global Hospitals Sales YoY Growth (2018-2034) & (K Pcs)
Figure 26. Product Picture of Clinics
Figure 27. Global Clinics Sales YoY Growth (2018-2034) & (K Pcs)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Global Antidiabetic Biguanides Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Antidiabetic Biguanides Sales Market Share by Application in 2022 & 2034
Figure 32. North America Antidiabetic Biguanides Sales Market Share in Volume by Application in 2022
Figure 33. North America Antidiabetic Biguanides Sales Market Share in Value by Application in 2022
Figure 34. Europe Antidiabetic Biguanides Sales Market Share in Volume by Application in 2022
Figure 35. Europe Antidiabetic Biguanides Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Antidiabetic Biguanides Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Antidiabetic Biguanides Sales Market Share in Value by Application in 2022
Figure 38. Latin America Antidiabetic Biguanides Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Antidiabetic Biguanides Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Antidiabetic Biguanides Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Antidiabetic Biguanides Manufacturing Cost Structure
Figure 43. Antidiabetic Biguanides Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries